ApprovalTrail

Approval · Notice of Compliance 3035 · 1998

GLYCON: Notice of Compliance 3035

Issued December 14, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3035
Date
December 14, 1998
Company
Icn Canada Ltd.Montreal, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New strength
Therapeutic class
Oral antihyperglycemic agent

Products in this notice

BrandDINStatus today
GLYCON02239214Dormant

Medicinal ingredients